Cargando…

SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus with a pandemic spread. So far, a total of 349,910 SARS-CoV-2 cases and 7687 deaths were reported in Croatia. We analyzed the seroprevalence and neutralizing (NT) antibody response in the Croatian general population...

Descripción completa

Detalles Bibliográficos
Autores principales: Vilibic-Cavlek, Tatjana, Stevanovic, Vladimir, Ilic, Maja, Barbic, Ljubo, Capak, Krunoslav, Tabain, Irena, Krleza, Jasna Lenicek, Ferenc, Thomas, Hruskar, Zeljka, Topic, Renata Zrinski, Kaliterna, Vanja, Antolovic-Pozgain, Arlen, Kucinar, Jasmina, Koscak, Iva, Mayer, Dijana, Sviben, Mario, Antolasic, Ljiljana, Milasincic, Ljiljana, Bucic, Lovro, Ferencak, Ivana, Kaic, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235035/
https://www.ncbi.nlm.nih.gov/pubmed/34203060
http://dx.doi.org/10.3390/pathogens10060774
_version_ 1783714222352367616
author Vilibic-Cavlek, Tatjana
Stevanovic, Vladimir
Ilic, Maja
Barbic, Ljubo
Capak, Krunoslav
Tabain, Irena
Krleza, Jasna Lenicek
Ferenc, Thomas
Hruskar, Zeljka
Topic, Renata Zrinski
Kaliterna, Vanja
Antolovic-Pozgain, Arlen
Kucinar, Jasmina
Koscak, Iva
Mayer, Dijana
Sviben, Mario
Antolasic, Ljiljana
Milasincic, Ljiljana
Bucic, Lovro
Ferencak, Ivana
Kaic, Bernard
author_facet Vilibic-Cavlek, Tatjana
Stevanovic, Vladimir
Ilic, Maja
Barbic, Ljubo
Capak, Krunoslav
Tabain, Irena
Krleza, Jasna Lenicek
Ferenc, Thomas
Hruskar, Zeljka
Topic, Renata Zrinski
Kaliterna, Vanja
Antolovic-Pozgain, Arlen
Kucinar, Jasmina
Koscak, Iva
Mayer, Dijana
Sviben, Mario
Antolasic, Ljiljana
Milasincic, Ljiljana
Bucic, Lovro
Ferencak, Ivana
Kaic, Bernard
author_sort Vilibic-Cavlek, Tatjana
collection PubMed
description Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus with a pandemic spread. So far, a total of 349,910 SARS-CoV-2 cases and 7687 deaths were reported in Croatia. We analyzed the seroprevalence and neutralizing (NT) antibody response in the Croatian general population after the first (May–July 2020) and second (December 2020–February 2021) pandemic wave. Initial serological testing was performed using a commercial ELISA, with confirmation of reactive samples by a virus neutralization test (VNT). A significant difference in the overall seroprevalence rate was found after the first (ELISA 2.2%, VNT 0.2%) and second waves (ELISA 25.1%, VNT 18.7%). Seropositive individuals were detected in all age groups, with significant differences according to age. The lowest prevalence of NT antibodies was documented in the youngest (<10 years; 16.1%) and the oldest (60–69/70+ years; 16.0% and 12.8%, respectively) age groups. However, these age groups showed the highest median NT titers (32–64). In other groups, seropositivity varied from 19.3% to 21.5%. A significant weak positive correlation between binding antibody level as detected by ELISA and VNT titer (rho = 0.439, p < 0.001) was observed. SARS-CoV-2 NT antibody titers seem to be age-related, with the highest NT activity in children under 10 years and individuals above 50 years.
format Online
Article
Text
id pubmed-8235035
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82350352021-06-27 SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia Vilibic-Cavlek, Tatjana Stevanovic, Vladimir Ilic, Maja Barbic, Ljubo Capak, Krunoslav Tabain, Irena Krleza, Jasna Lenicek Ferenc, Thomas Hruskar, Zeljka Topic, Renata Zrinski Kaliterna, Vanja Antolovic-Pozgain, Arlen Kucinar, Jasmina Koscak, Iva Mayer, Dijana Sviben, Mario Antolasic, Ljiljana Milasincic, Ljiljana Bucic, Lovro Ferencak, Ivana Kaic, Bernard Pathogens Article Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus with a pandemic spread. So far, a total of 349,910 SARS-CoV-2 cases and 7687 deaths were reported in Croatia. We analyzed the seroprevalence and neutralizing (NT) antibody response in the Croatian general population after the first (May–July 2020) and second (December 2020–February 2021) pandemic wave. Initial serological testing was performed using a commercial ELISA, with confirmation of reactive samples by a virus neutralization test (VNT). A significant difference in the overall seroprevalence rate was found after the first (ELISA 2.2%, VNT 0.2%) and second waves (ELISA 25.1%, VNT 18.7%). Seropositive individuals were detected in all age groups, with significant differences according to age. The lowest prevalence of NT antibodies was documented in the youngest (<10 years; 16.1%) and the oldest (60–69/70+ years; 16.0% and 12.8%, respectively) age groups. However, these age groups showed the highest median NT titers (32–64). In other groups, seropositivity varied from 19.3% to 21.5%. A significant weak positive correlation between binding antibody level as detected by ELISA and VNT titer (rho = 0.439, p < 0.001) was observed. SARS-CoV-2 NT antibody titers seem to be age-related, with the highest NT activity in children under 10 years and individuals above 50 years. MDPI 2021-06-20 /pmc/articles/PMC8235035/ /pubmed/34203060 http://dx.doi.org/10.3390/pathogens10060774 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Vilibic-Cavlek, Tatjana
Stevanovic, Vladimir
Ilic, Maja
Barbic, Ljubo
Capak, Krunoslav
Tabain, Irena
Krleza, Jasna Lenicek
Ferenc, Thomas
Hruskar, Zeljka
Topic, Renata Zrinski
Kaliterna, Vanja
Antolovic-Pozgain, Arlen
Kucinar, Jasmina
Koscak, Iva
Mayer, Dijana
Sviben, Mario
Antolasic, Ljiljana
Milasincic, Ljiljana
Bucic, Lovro
Ferencak, Ivana
Kaic, Bernard
SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia
title SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia
title_full SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia
title_fullStr SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia
title_full_unstemmed SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia
title_short SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia
title_sort sars-cov-2 seroprevalence and neutralizing antibody response after the first and second covid-19 pandemic wave in croatia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235035/
https://www.ncbi.nlm.nih.gov/pubmed/34203060
http://dx.doi.org/10.3390/pathogens10060774
work_keys_str_mv AT vilibiccavlektatjana sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia
AT stevanovicvladimir sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia
AT ilicmaja sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia
AT barbicljubo sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia
AT capakkrunoslav sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia
AT tabainirena sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia
AT krlezajasnalenicek sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia
AT ferencthomas sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia
AT hruskarzeljka sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia
AT topicrenatazrinski sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia
AT kaliternavanja sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia
AT antolovicpozgainarlen sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia
AT kucinarjasmina sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia
AT koscakiva sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia
AT mayerdijana sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia
AT svibenmario sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia
AT antolasicljiljana sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia
AT milasincicljiljana sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia
AT buciclovro sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia
AT ferencakivana sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia
AT kaicbernard sarscov2seroprevalenceandneutralizingantibodyresponseafterthefirstandsecondcovid19pandemicwaveincroatia